Wong et al. [94] tested the effects of the CDK4/6 inhibitor palbociclib in cell lines from anaplastic thyroid cancers and in mice carrying a xenograft of human anaplastic thyroid cancer. Here, CDK4 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.